Introduction Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease of the
elderly, treated mainly with systemic corticosteroids. The frequency of side effects of steroids …

Objectives The need for glucocorticoid-sparing drugs (GCSD) remains an important issue
and is an unmet need in the treatment of polymyalgia rheumatica (PMR). We therefore …

Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR)
but induce adverse events. Objectives To evaluate the efficacy and safety of first-line …

A systematic review and meta-analysis were conducted, according to the PRISMA
methodology, to summarize current evidence on the prevalence and predictors of long-term …

Background Polymyalgia rheumatica (PMR) treatment is based on low-dose glucocorticoids.
Glucocorticoid-sparing agents have also been tested. Our objective was to systematically …

Iread with great interest Floris et al.'s review article, recently accepted for publication [1]. As
emerged in their systematic review and meta-analysis, conflicting results have been …

Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease
in older people after rheumatoid arthritis. According to the 2015 EULAR-ACR …

The objective of this study was to analyze the clinical, laboratorial, and therapeutical
response of polymyalgia rheumatica (PMR) to anti-tumor necrosis factor (anti-TNF) …

Introduction/objectives Polymyalgia rheumatica (PMR) is a common inflammatory disorder
that is usually managed with oral glucocorticoids, which although effective can cause …

Patient-reported outcomes (PROs) are being increasingly recognized as important
measures by rheumatologists. The objective of this review was to evaluate the frequency of …